Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative review.

Bantounou, Maria A; Plascevic, Josip; MacDonald, Lewis; Wong, Man Chun; O'Connell, Neasa; Galley, Helen F

Bantounou, Maria A; Plascevic, Josip; MacDonald, Lewis; Wong, Man Chun; O'Connell, Neasa; Galley, Helen F.

Afiliación

Bantounou MA; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Plascevic J; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
MacDonald L; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Wong MC; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
O'Connell N; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Galley HF; School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.

Curr Urol ; 17(4): 271-279, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37994340

Palabras clave

Antibody-drug conjugate; Bladder; Checkpoint inhibitor; Review; Urothelial carcinoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Curr Urol Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google